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The first Croatian pediatric patient with Geotrichum capitatum
respiratory infection
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Geotrichum capitatum can cause infections in humans and its importance has
recently been recognized in patients with immunosuppressive conditions. In
this report we present the first Croatian pediatric patient with pneumonia in
whom G. capitatum was isolated in three sequential bronchoalveolar lavage and
tracheal aspiration specimens. 
Prikaz bolesnika
Geotrichum capitatum mo`e uzrokovati infekcije u ljudi i njegov zna~aj je ne-
davno prepoznat u imunosuprimiranih bolesnika. U ovom radu prikazujemo pr-
vog hrvatskog pedijatrijskog bolesnika s pneumonijom u kojeg je G. capitatum
izoliran u tri uzastopna bronhoalveolarna lavata i aspirata traheje.
Introduction
Geotrichum capitatum is a filamentous yeast-like fun-
gus formerly known as Trichosporon capitatum or Blasto-
shizomyces capitatus. Although it can be a part of the nor-
mal microbiota it can also cause both superficial and inva-
sive infections in humans [1, 2]. It forms creamy, wrinkled
colonies that grow on conventional media such as
Sabouraud dextrose agar [1]. It is occasionally encoun-
tered in clinical laboratories and its importance as sys-
temic pathogen has recently been recognized in patients
with immunosuppressive conditions [3]. Studies have
shown that there is a significantly higher frequency of in-
fections caused by G. capitatum in Europe, with majority
of them occurring in Italy, Spain, and France [4].  Since
most cases were located in central and southern Europe, it
seems that the epidemiology of G. capitatum infections
could be influenced by climatic factors. The mortality in
patients with G. capitatum infections is high (60 %) [5].
In this report we present, to our knowledge, the first
pediatric patient from Croatia in whom the Geotrichum
capitatum was isolated in three sequential bronchoalveo-
lar lavage (BAL) and tracheal aspiration specimens. 
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fixime oral suspension was administered. Despite the an-
timicrobial therapy he continued to be febrile, drank poor
and became less responsive to stimuli. He was brought to
our pediatric emergency room and subsequently admitted
to the pediatric intensive care unit (PICU) with signs of
shock requiring appropriate fluid resuscitation therapy and
inotropic support. Laboratory tests showed mild leukocy-
tosis (12.8 × 109/L), anemia (hemoglobin 90 g/L; hemat-
ocrit 0.32) and moderately increased CRP (89.7 mg/L).
Chest X-ray (Figure 1.) confirmed rightsided broncho-
pneumonia with complete atelectasis of the left lung. His
regular chronic therapy was continued and parenteral an-
timicrobial therapy with ceftriaxone was initiated.  
Despite the intense inhalational and other symptomatic
therapy, his respiratory condition worsened. Therefore, he
was sedated, intubated and mechanical ventilation was ini-
tiated. Because of the atelectasis and thick and abundant
secretion in his lower airways, in addition to regular phys-
ical respiratory therapy and frequent tracheal aspiration,
an aspiration of lower airways with fiberoptic broncho-
scope was also done and the first BAL specimen was sent
for microbiology analysis. He was fed by parenteral nutri-
tion. The following day, due to further increase of inflam-
matory biomarkers (procalcitonin >100 ng/mL), parenter-
al meropenem was administered. He was also given a
blood transfusion. Three days later, Geotrichum capitatum
Case report
A 6-year-old boy was referred to the University
Hospital of Split with a two and a half week intermittent
fever duration. He was born after an uneventful pregnancy
and soon after the birth was diagnosed with multimalfor-
mation syndrome (frontal bossing, low posterior hairline,
dysplastic ears, flat nasal bridge, gingival hyperplasia, ir-
regular dentition, high-arched palate) and early epileptic
encephalopathy (seizures with delayed psychomotor de-
velopment – unable to walk, minimal visual contact, se-
vere speech impairment). His previous hospitalization in
our Department was a year before due to pneumonia and
respiratory insufficiency. During that hospitalization he
was mechanically ventilated for 9 days. He was dis-
charged home with his regular anticonvulsive therapy and
the parents were educated to administer noninvasive ven-
tilatory support. His present illness started 17 days prior to
hospitalization with fever and upper respiratory tract in-
fection symptoms. The boy was examined by his primary
care physician who prescribed amoxicillin oral suspen-
sion. After eight days of antimicrobial treatment his con-
dition improved. However, three days before the hospital
admission he became febrile up to 40.0 °C with increased
respiratory effort. He was clinically reexamined by his
primary care physician the day later. Laboratory blood
tests were done (L 14.5 G/L, CRP 67.0 mg/L) and ce-
Figure 1. Chest x-ray at the time of hospital admission
Slika 1. Radiogram plu}a u vrijeme prijema u bolnicu
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and Candida albicans were confirmed in BAL and flu-
conazole was administered. BAL specimens were cul-
tured on blood agar, Sabouraud agar (Merck KgaA, Darm-
stadt, Germany) and CHROMagar Candida (CHROM-
agar Orientation, Paris, France). After 24 hours of incuba-
tion on two temperature conditions (25 °C and 36 °C) two
types of colonies were revealed. The total number of
growing colonies was > 105 colony forming units (CFU)/
ml of BAL. On the CHROMagar Candida media green
colonies of Candida albicans were positive in germ tube
formation, confirming Candida albicans identification.
On the Sabouraud agar diferent type of cream coloured
dry and wrinkled colonies were observed. These colonies
showed no germ tube formation. Microscopic view and
microcultivations on cornmeal agar (25 °C and 35 °C) re-
vealed abundant thin, septate filaments with multiple rec-
tangular arthroconidia and the absence of blastoconidia
and chlamydospores. The isolate was identified as G. cap-
itatum according to the biochemical patterns obtained by
the VITEK 2 System (bioMerieux, Marcy-l'Etoile, France)
using YST card. Gradually, his condition improved and
inotropic support was discontinued. Candida albicans
and Geotrichum capitatum were again isolated in the sec-
ond BAL taken two days later. Therefore, fluconazole was
replaced with intravenous amphotericin B and voricona-
zole. At the same time, coagulase negative Staphylococ-
cus sp. was isolated from the blood culture and teicoplanin
was administered as well. The patient's condition contin-
ued to improve but we were not able to wean him of the
mechanical ventilation. By the end of the second week of
treatment he again became hemodynamically unstable
with symptoms and laboratory signs (L 15.7 × 109/L; CRP
299.4 mg/L; procalcitonin 3.95 ng/mL) of sepsis requiring
inotropic support. Eight days after initiation of ampho-
tericin B and voriconazole treatment, G. capitatum was
isolated again, this time from tracheal aspirate specimen.
Blood culture was sterile. Amikacin and micafungin were
added to the treatment regime. However, his condition
continued to deteriorate with further increase of inflam-
matory biomarkers (CRP 377.1 mg/L, procalcitonin 81.65
ng/mL). Despite all intensive treatment and therapy, on
the 18th day, he developed bradycardia leading to asystole
and death.
Discussion
In this report we describe the first Croatian pediatric
non-hematologic patient with pulmonary infection caused
by Geotrichum capitatum. Prior to hospitalization the pa-
tient was treated with oral antibiotics and admitted to
PICU requiring mechanical ventilation and intensive
treatment.
Fungi are part of normal microbiota and some of them
are considered nonpathogenic. However, they can cause
systemic infections in patients that are severely immuno-
compromised due to illness or therapy with immunosup-
pressive drugs [6]. Most fungal infections are caused by
Candida spp., but the frequency of other rare molds and
unusual yeasts is increasing. Risk factors for fungal infec-
tions include hospitalization in ICU, prolonged therapy
with broad-spectrum antibiotics and steroids, central ve-
nous catheter, total parenteral nutrition, neutropenia and
previous colonisation [6, 7, 8].
Geotrichum capitatum has emerged as a fungal pathogen
in recent years. Invasive fungal infections caused by this
agent are often characterized by a multiorgan involvement
with a fatal course despite antifungal therapy. Numerous
studies have shown increased occurrence of Geotrichum
capitatum infection in patients with impaired immune re-
sponse to infection [3, 4, 9]. In a study that involved 353
immunocompromised patients over a 37 months period,
colonisation and infection by G. capitatum was found in
3.7% of them [3]. Most of the studies published so far
have described the infection caused by G. capitatum in
adult patients, but some of them also described infection
with this pathogen in immunocompromised children [9,
10]. Infection is also possible in immunocompetent pa-
tients. Usually it will affect middle to older-aged males
with underlying lung pathology (chronic obstructive pul-
monary disease, tuberculosis) or with risk factors like
smoking or previous transplantation [11].
The pulmonary localization is commonly reported in
G. capitatum septicemia and the radiological signs resem-
ble those found in invasive pulmonary aspergillosis [4].
In our patient, laboratory and clinical signs strongly
suggest that G. capitatum and C. albicans were cause of res-
piratory tract infection. They were not isolated from blood
cultures. Since the susceptibility testing of G. capitatum
has not yet been established due to the absence of break-
points, the treatment of these infections is based on empir-
ical terapy according to limited available literature data. 
Currently, there are no official guidelines concerning
the most effective antifungal therapy for G. capitatum in-
fection. The therapy with azoles is widely used as effec-
tive in the treatment of yeast infections. It is also suggest-
ed that azoles should be used as first-line agents in patients
like ours [11]. However, our initial antimicotic therapy
with fluconazole seemed to be inefficient. This may be
due to resistance or decreased susceptibility of G. capita-
tum to fluconazole. Therefore, fluconazole was replaced
with voriconazole and amphotericin B combination thera-
py. Based on limited clinical data available, amphotericin
B and voriconazole are also recommended to be used,
alone or in combination. Same authors reported poor sus-
ceptibility of some strains to flucytosine, fluconazole and
itraconazole [4]. However, in our patient, this combina-
tion therapy eradicated C. albicans, but G. capitatum re-
mained positive in tracheal aspiration specimen. There-
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fore, further studies evaluating optimal treatment, dosage
and duration of therapy are warranted. It may be possible
that failure of antimycotic treatment, combined with other
factors, such as underlying diseases, hospitalization in
PICU and concomitant bacterial sepsis, could be the rea-
sons for undiserable outcome.
Aretrospective study and review published in 2005 has
shown that the majority of infections caused by G. capita-
tum occurred in Europe, mostly in the Mediteranean area
to which Croatia belongs [4]. Therefore, physicians prac-
ticing in this area have to consider G. capitatum as a possi-
ble cause of infection if an immunocompromised or even
immunocompetent patient shows signs of persistent infec-
tion despite the broad spectrum antibacterial therapy.
Although this is, to our knowledge, the first described
case of G. capitatum infection in a pediatric patient from
Croatia, pediatricians should take into consideration this
filamentous yeast-like fungus as a possible cause of infec-
tion as well.
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